11.03.2022 - WILMINGTON, Del., March 11, 2022 (GLOBE NEWSWIRE) - Prelude Therapeutics Inc. (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that Kris Vaddi, PhD, Chief Executive Officer, will participate in a fireside chat at the ...